Schedule 13D ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: 2020-12-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000947
- Form type
- SC 13D
- Filer
- Kinnate Biopharma Inc.
- CIK
- CIK 1797768
- Filed
- Dec 11, 2020
- Reporting period
- Dec 02, 2020
- Description
- Schedule 13D beneficial ownership